Advertisement

Topics

Companies Related to "Advancing tools clinical drug development through intercontinental collaboration" [Most Relevant Company Matches] RSS

16:47 EST 16th February 2019 | BioPortfolio

Here are the most relevant search results for "Advancing tools clinical drug development through intercontinental collaboration" found in our extensive corporate database of over 50,000 company records.

Showing "Advancing tools clinical drug development through intercontinental collaboration" Companies 1–25 of 12,000+

Relevant

Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by advancing them through the drug discovery and development process in a cost-efficient manner. Development programs are designed and driven by a core team with extensive drug development ...


Intercontinental Exchange

Intercontinental Exchange (NYSE: ICE) is the leading network of regulated exchanges and clearing houses for financial and commodity markets. ICE delivers transparent, reliable and accessible data, technology and risk management services to markets around the world through its portfolio of exchanges, including the New York Stock Exchange and ICE Futures. ...

Clinical Data, Inc.

Clinical Data develops first-in-class and best-in-category therapeutics. The Company is advancing its late-stage drug candidates for central nervous system disorders and cardiovascular diseases, to be followed by promising drug candidates in other major therapeutic areas. Clinical Data combines its drug development and biomarker expertise in an effort to d...


American InterContinental University

Founded in Europe in 1970, American InterContinental University offers a wide range of undergraduate and graduate degrees in programs such as business, healthcare, IT, design, criminal justice and education at campuses in Atlanta and Houston and an Internet-based online campus headquartered in suburban Chicago. AIU is accredited by The Higher Learning Comm...

ACADIA Pharmaceuticals Inc.

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is currently developing a portfolio consisting of four product candidates including pimavanserin, which is being developed for three separate neurological and psychiatric indi...

Merrimack Pharmaceuticals,Inc.

Merrimack Pharmaceuticals, Inc. is a privately held biotechnology company based in Cambridge, Massachusetts. We are dedicated to the discovery and development of innovative therapies for the treatment of autoimmune disease and cancer. Our goal is to provide patients and physicians with not only the best possible treatments, but to support our pharmaceuticals with the tools to enable the prescrip...

TransPharma Medical Ltd.

Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing its proprietary active transdermal drug delivery technology. The company aims to develop multiple drug products through strategic partnerships with leading pharmaceutical companies and through indep...

London Genetics Ltd

London Genetics Limited, a not-for-profit company, is an expert in the use of pharmacogenetics in clinical drug discovery and development. Established in 2007 with funding from the London Development Agency, its seven founding partners are leading London academic and medical institutions with clinical and genetic expertise and significant patient resources. The company provides pharmaceutical ...

Crown Bioscience, Inc.

Crown Bioscience, Inc. is a U.S.-based drug discovery service company with R&D facilities in China committed to advancing anti-cancer therapeutics through the preclinical and drug development stages. Its proprietary CrystalClearTM , HuPrime™ and HuKemia™ platforms enable unique lead optimization and translational oncology strategies to deliver ...

Embera NeuroTherapeutics Inc.

Embera NeuroTherapeutics, Inc. is a development-stage pharmaceutical company focused on treating a broad range of addictions where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions related to stress response that drive craving and relapse a...

Kosan Biosciences

Kosan Biosciences is an established cancer therapeutics company focused on advancing two new classes of anticancer agents through clinical development: heat shock protein 90 (Hsp90) inhibitors and epothilones. Kosan has built an industry-leading position in Hsp90 inhibitors. Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival....

InSite Vision Inc.

InSite Vision is advancing new specialty ophthalmic products for the treatment of diseases affecting the front and back of the eye. The company has two commercial products based on its innovative DuraSite® platform approved for the treatment of bacterial eye infections, AzaSite® (azithromycin ophthalmic solution) 1%, marketed in the U.S. by Akorn, In...

Lipomics Technologies Inc.

Lipomics Technologies provides industry leading metabolic profiling for drug discovery and development, patient monitoring and personalized medicine. The Company's proprietary analytical technologies generate a comprehensive, accurate and quantitative profile of lipid metabolites. A broad range of bioinformatics and analytical tools map these profiles to activity levels of underlying biochemical p...

Viventia Biotech Inc

Viventia Biotech Inc. is a biopharmaceutical company advancing a new generation of monoclonal antibody therapeutics designed to offer safer, more beneficial therapies for cancer patients. Viventia’s lead product candidate Proxinium™ continues on an aggressive clinical development schedule. Viventia has initiated a Phase II North American clinical trial and concurrently commenced a pivotal Phas...

Ascenta Therapeutics, Inc.

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company located in the Greater Philadelphia area. The company is dedicated to efficient oncology drug development and has a portfolio of apoptosis-triggering small molecules that target protein-protein interactions, including two clinical compounds AT-101 and AT-406. In June 2010, A...

PharmaNet Development Group

PharmaNet Development Group, a global, drug development services company, provides expertise to the pharmaceutical, biotechnology, generic drug, and medical device industries. PharmaNet companies offer clinical-development solutions including consulting services, Phase I clinical studies, bioequivalency and pharmacodynamic studies, bioanalytical analyses, and Phase II, III, and IV clinical develop...

ADC Therapeutics Sarl

ADC Therapeutics (ADCT) is a Swiss-based oncology drug development company that specializes in the development of proprietary Antibody Drug Conjugates (ADCs) targeting major cancers such as breast lung, prostate, renal and blood. The Company’s ADCs are highly targeted drug constructs which combine monoclonal antibodies specific to particular types of ...

Triphase Accelerator Corporation

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to advancing novel compounds through Phase 2 proof-of-concept clinical studies using a unique, science-based, high-quality model that is faster and more cost-effective than traditional p...

Embera NeuroTherapeutics, Inc.

Embera NeuroTherapeutics, Inc. is a development stage pharmaceutical company focused on treating a broad range of addictions and obesity where the major clinical challenge is a limited range of effective drug therapies. Embera is developing a novel drug combination (EMB-001) targeting specific brain functions that drive craving and relapse associated with ...

Icagen, Inc.

Icagen, Inc. is a biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. Utilizing its proprietary know-how and integrated scientific and drug development capabilities, Icagen has identified multiple drug candidates that modulate i...

Akaal Pharma Pty Limited

Akaal Pharma is a private clinical-stage, Australian biotech company focused on advancing the clinical development of its internally discovered topical and oral small molecule drug candidates for treating inflammatory, immune and vascular diseases specifically atopic dermatitis, psoriasis, arthritis, pain, nephropathy, retinopathy, multiple sclerosis, ulce...

Physiome Sciences Incorporated

Physiome Sciences, Inc. is a privately held company that develops integrated software tools, complex databases and application frameworks for constructing experimentally detailed computer-based models of cells, organs and systems using data from a wide variety of sources. These models provide a virtual environment for filtering information, developing hypotheses and creating a shared knowledge bas...

Zalicus Inc

Zalicus focuses its internal drug development efforts on pain and immuno-inflammatory diseases. Our pipeline for pain includes Exalgo™ (hydromorphone HCl) extended-release tablets (marketed by Covidien), for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended per...

Ipsogen, Inc

Ipsogen foresees cancer, the second leading cause of death in developed countries, as a unique domain where drug development, commercialisation and prescription can benefit from biomarker discovery, validation and use as companion diagnostics:• Cancer patients require accurate assessment of their disease to optimise the use of existing drugs and to access new innovative targeted therapies.• On...

Alzheon, Inc.

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. Alzheon pursues drug development programs that have previously been tested in extensive efficacy studies in Alzheimer’s disease patients and where new i...


More From BioPortfolio on "Advancing tools clinical drug development through intercontinental collaboration"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks